Inotiv, Inc.
NCM: NOTVLive Quote
📈 ZcoreAI Score
Our AI model analyzes Inotiv, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get NOTV Z-Score →About Inotiv, Inc.
Healthcare
Diagnostics & Research
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
📊 Fundamental Analysis
Inotiv, Inc. demonstrates a profit margin of -13.5%, which is below the sector average, suggesting competitive pressure.
The company recently reported 0.8% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is -49.8%, which indicates that capital utilization is currently under pressure.
At a current price of $0.23, NOTV currently trades near the bottom of its 52-week range (0%), indicating potential value or weakness (Range: $0.22 - $3.32).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$7.88M
Trailing P/E
--
Forward P/E
-4.58
Beta (5Y)
4.08
52W High
$3.32
52W Low
$0.22
Avg Volume
445K
Day High
Day Low